The system described comprises a respiratory therapy flow device, a respiratory circuit, and an exhalation valve. The device includes an exhalation pressure control port. The exhalation valve is removably engaged with the exhalation pressure control port and the respiratory circuit. The valve comprises a lid, a diaphragm, and a housing body. The housing body comprises a ramped lock configured to engage the respiratory therapy flow device at the exhalation pressure control port. Responsive to an engagement between the valve and the exhalation pressure control port, the lid forms a compression seal with the exhalation pressure control port, the diaphragm forms a compression seal with the lid, and the diaphragm is selectively controlled via gas pressure received through the exhalation pressure control port such that gas in the respiratory circuit flows to the ambient atmosphere during exhalation by the subject.

Disclosed is a fluid trap for use with, or comprising part of, a respiratory therapy system, and in particular comprising part of, or configured to be connected to, a breathing limb, such as an expiratory limb, of a respiratory therapy system. The fluid trap comprises a container configured to contain fluid received from an inlet; a closure, the closure and container being configured to be removeably mounted together to close the container; and a valve configured to be removeably mounted on at least one of the container and the closure, and configured to be in a closed condition which prevents fluid from flowing through the inlet when the closure is not mounted on the container, the valve being further configured to be in an open position which allows fluid from the inlet into the container when the closure is mounted on the container.

Systems and methods for non-invasive ventilation are provided. The systems may include a gas source that provides breathing gases to a patient through one or more of a primary flow path (PFP) and a flushing flow path (FFP). The system may include a control assembly configured to open and restrict gas flow through the PFP. When the PFP is open, a significant portion of the gas flows through the PFP while the remaining gas flows through the FFP. When the PFP is restricted, a significant portion of the gas flows through the FFP. Increased flow through the FFP may have a high velocity (especially relative to the flow through the PFP). Gas delivered through the FFP may be used to flush dead space. One or both flow paths may contribute to inspiratory positive airway pressure (IPAP), expiratory positive airway pressure (EPAP), and/or positive end expiratory pressure (PEEP).

The invention discloses a gas valve (11) for ventilation, comprising a main body (12) having a first gas chamber (13), a second gas chamber (15) and at least an inlet duct (14) for supplying a gas to the first gas chamber (13). The gas valve (11) further comprises a proportional valve (24) for temporally sealing the first gas chamber (13) from the second gas chamber (15). The second gas chamber (15) comprises at least a second passage opening (22) for releasing the gas from the second gas chamber (15) and the second gas chamber (15) comprises a port (30) for connecting a pressure measurement apparatus for measuring the gas pressure in the second gas chamber (15). The invention further discloses a circuit with a ventilation limb comprising a gas valve (11) and a method for determining a releasing gas flow of a gas valve.

A mechanical ventilation system comprises a plurality of ventilation therapy sub-systems. Each of the ventilation therapy sub-systems is adapted to assist a respiratory function of the patient. The system also comprises a detector of the respiratory drive of the patient, an operator interface receiving one or more control parameters, and a main controller. The main controller assigns a therapeutic contribution to each of the ventilation therapy sub-systems based on the respiratory drive of the patient and on the control parameters. The controller modulates the respiratory drive of a patient by controlling each of the plurality of the ventilation therapy sub-systems according to its assigned therapeutic contribution. Distinct ventilation therapy sub-systems may apply negative pressure on the abdomen of the patient, deliver a non-pressurizing inspiratory flow to the patient, or induce a positive pressure in the airways of the patient.

Systems and methods for non-invasive ventilation are provided. The systems may include a gas source that provides breathing gases to a patient through one or more of a primary flow path (PFP) and a flushing flow path (FFP). The system may include a control assembly configured to open and restrict gas flow through the PFP. When the PFP is open, a significant portion of the gas flows through the PFP while the remaining gas flows through the FFP. When the PFP is restricted, a significant portion of the gas flows through the FFP. Increased flow through the FFP may have a high velocity (especially relative to the flow through the PFP). Gas delivered through the FFP may be used to flush dead space. One or both flow paths may contribute to inspiratory positive airway pressure (IPAP), expiratory positive airway pressure (EPAP), and/or positive end expiratory pressure (PEEP).

A bi-level positive airway pressure device includes a housing that has a patient port for connecting to an airway of a patient. There is a device (e.g., a nozzle) for generating a positive airway pressure that is directed through a conduit towards the patient port. An exhalation detector includes a nozzle emitting a jet of a gas directed across the conduit and directed at a receptor channel when exhalation gases flow from the patient port, thereby an increase a gas pressure is present at the receptor channel when the exhalation gases flow from the patient port. The exhalation detector converts the increase in the gas pressure into a movement of an occluding member such that when the exhalation gases flow from the patient port, the occluding member moves to block the means for generating the positive airway pressure.

A respiratory delivery system providing a bi-level pressure airflow. The system includes respiratory and pneumatic circuits. The respiratory circuit includes a respiratory gas supply, a patient interface, and a bi-level pressure regulator. The respiratory gas supply supplies a respiratory gas to the patient interface via a first conduit. The bi-level pressure regulator is coupled to the patient interface via a second conduit and is configured to cyclically alternate the respiratory gas passing through the bi-level pressure regulator between a low-pressure level and a high-pressure level. The pneumatic circuit includes a pneumatic gas supply and a pneumatic cycler configured to output a cycling pressure level. The cycler is coupled to the bi-level pressure regulator via a third conduit. The bi-level pressure regulator cyclically alternates the pressure level of the respiratory gas between the low-pressure level and the high-pressure level with the timing defined by the cycling of the pneumatic gas.

PEEP-valves configured to be placed inline with the exhalation path of a ventilator and ahead of the exhalation valve. The PEEP-valve functions as a resistor that can provide a higher PEEP value for any given PIP, lung compliance, and respiratory rate combination compared to a standard PIP to PEEP ratio.

Systems and methods for non-invasive ventilation are provided. The systems may include a gas source that provides breathing gases to a patient through one or more of a primary flow path (PFP) and a flushing flow path (FFP). The system may include a control assembly configured to open and restrict gas flow through the PFP. When the PFP is open, a significant portion of the gas flows through the PFP while the remaining gas flows through the FFP. When the PFP is restricted, a significant portion of the gas flows through the FFP. Increased flow through the FFP may have a high velocity (especially relative to the flow through the PFP). Gas delivered through the FFP may be used to flush dead space. One or both flow paths may contribute to inspiratory positive airway pressure (IPAP), expiratory positive airway pressure (EPAP), and/or positive end expiratory pressure (PEEP).